文献速递心脑血管急症重症综合管理与镇静镇痛

心肌梗死相关心源性休克中MMP-9活性受抑提示RAGE降解减少

Suppressed MMP-9 Activity in Myocardial Infarction-Related Cardiogenic Shock Implies Diminished Rage Degradation.
PubMed 文献 · Shock · 2017-01-01
一句话结论急性心肌梗死患者血清MMP-9活性升高,但合并心源性休克时显著降低,非存活者最低,MMP-9活性与单核细胞RAGE表达呈负相关。

该研究检测了心肌梗死后心源性休克患者(CS,n=30)、无休克急性心肌梗死患者(AMI,n=20)和健康志愿者(n=20)的血清MMP-9活性(酶谱法)及TIMP-1表达(Western blot),并与RAGE/sRAGE数据关联。MMP-9活性在AMI中较对照组升高(P=0.02),但在CS中显著降低,非存活者(n=13)最低(P=0.02 vs AMI)。所有患者中MMP-9活性与循环单核细胞RAGE表达呈负相关(r=-0.57;P=0.0001;n=50)。TIMP-1与活性MMP-9呈反向调节:AMI较对照组显著降低(P=0.02),CS非存活者最高(P<0.001 vs AMI)。作者认为维持MMP-9活性可能是限制心源性休克中RAGE诱导有害炎症的治疗靶点。

要点

  • 急性心肌梗死患者血清MMP-9活性较健康对照升高(P=0.02),但合并心源性休克时显著降低,非存活者最低(P=0.02 vs AMI)。
  • 所有患者中MMP-9活性与循环单核细胞RAGE表达呈负相关(r=-0.57;P=0.0001;n=50)。
  • TIMP-1在AMI中较对照显著降低(P=0.02),在CS非存活者中最高(P<0.001 vs AMI),与活性MMP-9反向调节。
  • 作者认为维持MMP-9活性可能是限制心源性休克中RAGE诱导有害炎症的治疗靶点。

适用人群与场景

  • 急性心肌梗死后心源性休克患者(CS,n=30)
  • 急性心肌梗死无休克患者(AMI,n=20)
  • 健康志愿者(n=20)

研究设计与关键结果

  • 研究类型为病例对照研究,比较CS(n=30)、AMI(n=20)和健康志愿者(n=20)的血清MMP-9活性(酶谱法)和TIMP-1表达(Western blot)。
  • MMP-9活性在AMI中较对照组升高(P=0.02),但在CS中显著降低,非存活者(n=13)最低(P=0.02 vs AMI)。
  • 所有患者中MMP-9活性与循环单核细胞RAGE表达呈负相关(r=-0.57;P=0.0001;n=50)。
  • TIMP-1在AMI中较对照组显著降低(P=0.02),在CS非存活者中最高(P<0.001 vs AMI)。

证据类型、等级与局限

  • 证据类型:病例对照研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为维持MMP-9活性可能是限制心源性休克中RAGE诱导有害炎症的治疗靶点。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Receptor for advanced glycation end products (RAGE) and its cleavage fragment soluble RAGE (sRAGE) are opposite players in inflammation. Enhanced monocytic RAGE expression and decreased plasma sRAGE levels are associated with higher mortality in infarction-related cardiogenic shock. Active matrix metalloproteinase-9 (MMP-9) has been implied in RAGE ectodomain cleavage and subsequently sRAGE shedding in vitro. We investigated MMP-9 activity in myocardial infarction-induced cardiogenic shock with regard to RAGE/sRAGE regulation.

METHODS AND RESULTS: We determined MMP-9 serum activity by zymography and tissue inhibitor of matrix metalloproteinases (TIMP-1) expression by Western blot and correlated it to RAGE/sRAGE data in patients with cardiogenic shock after acute myocardial infarction (CS, n = 30), in patients with acute myocardial infarction without shock (AMI, n = 20) and in healthy volunteers (n = 20).MMP-9 activity is increased in AMI (P = 0.02 versus controls), but significantly decreased in CS with lowest levels in non-survivors (n = 13, P = 0.02 versus AMI). In all patients, MMP-9 activity correlated inversely with RAGE expression on circulating monocytes (r = -0.57; P = 0.0001; n = 50).TIMP-1 levels showed an inverse regulation in comparison to active MMP-9 with significantly decreased levels in AMI as compared with controls (P = 0.02 versus controls) and highest levels in non-survivors of CS (P <0.001 versus AMI).

CONCLUSIONS: Serum MMP-9 activity is increased in acute myocardial infarction, but markedly suppressed in cardiogenic shock. Maintaining MMP-9 activity could be a therapeutic target to limit RAGE-induced deleterious inflammation in cardiogenic shock.

来源:Shock,查看原文。版权归原作者所有。

参考来源

  1. Selejan SR, Hewera L, Hohl M, et al. Suppressed MMP-9 Activity in Myocardial Infarction-Related Cardiogenic Shock Implies Diminished Rage Degradation. Shock. 2017. PMID: 28608784. doi:10.1097/SHK.0000000000000829

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。